Is Cumulative Life Course Impairment Considered in Psoriasis Management? A Multinational Survey of People with Psoriasis and Healthcare Professionals
Misalignment exists in the experience of people living with psoriasis versus its assessment in clinical practice. Support is needed for assessment and monitoring of elements that may contribute to CLCI in clinical practice worldwide, to guide early psoriasis treatment decision-making to mitigate the risk for CLCI. Infographic available for this article. INFOGRAPHIC.
Authors
- Matthias Augustin (ORCID: https://orcid.org/0000-0002-4026-8728)
- April Wang Armstrong (ORCID: https://orcid.org/0000-0003-0064-8707)
- Rhiannon Elizabeth Matthews (ORCID: https://orcid.org/0000-0003-3449-4451)
- J.M. Carrascosa (ORCID: https://orcid.org/0000-0003-4266-0771)
- Christopher Baker (ORCID: https://orcid.org/0009-0003-0144-2927)
- Richard G. Langley (ORCID: https://orcid.org/0000-0003-4730-2164)
- Adam Reich (ORCID: https://orcid.org/0000-0002-5573-1754)
- Sandy McBride (ORCID: https://orcid.org/0000-0002-8449-1809)
- Francesca Sampogna (ORCID: https://orcid.org/0000-0002-7624-3290)
- Brian Kirby (ORCID: https://orcid.org/0000-0001-7596-892X)
- Ricardo Romiti (ORCID: https://orcid.org/0000-0003-0165-3831)
- Richard Bruce Warren (ORCID: https://orcid.org/0000-0002-2918-6481)
Institutions
- University College Dublin (IE)
- Dalhousie University (CA)
- Universität Hamburg (DE)
- University of California, Los Angeles (US)
- Royal Free London NHS Foundation Trust (GB)
- Universidade de São Paulo (BR)
- Manchester Academic Health Science Centre (GB)
- St Vincent's Hospital Melbourne (AU)
- University Medical Center Hamburg-Eppendorf (DE)
- Istituto Dermopatico dell'Immacolata (IT)
- Hospital Universitari Germans Trias i Pujol (ES)
- NIHR Manchester Biomedical Research Centre (GB)
- Universidade Federal de São Paulo (BR)
- University of Rzeszów (PL)
Publication Details
- Journal
- Dermatology and Therapy
- Published
- 2025-11-22
- DOI
- https://doi.org/10.1007/s13555-025-01573-1
- Primary Topic
- Psoriasis: Treatment and Pathogenesis
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Amgen
- Bristol-Myers Squibb
- Eli Lilly and Company
- Pfizer
- AstraZeneca
- Sanofi
- Galderma
- Royal College of Physicians of Ireland
- LEO Pharma